Top Back to top

7th Edition (effective June 1st, 2018)

The seventh edition of the FACT-JACIE International Standards for Haematopoietic Cellular Therapy Product Collection, Processing, and Administration was published on March 1, 2018, and will be implemented beginning in June 2018. These Haematopoietic Cell Therapy Standards apply to haematopoietic progenitor cells, defined as self-renewing and/or multi-potent stem cells capable of maturation into any of the haematopoietic lineages, lineage-restricted pluri-potent progenitor cells, and committed progenitor cells from haematopoietic sources (bone marrow, umbilical cord blood, peripheral blood, or other tissue source). These Standards also include mononuclear cells, defined as nucleated cells from any haematopoietic tissue source (marrow, peripheral blood, umbilical cord, and placental blood) collected for therapeutic use other than as haematopoietic progenitor cells.

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to